University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Apixaban

Specialist initiation for the treatment and secondary prevention of DVT and/or PE - use in line with NICE and supported by RICaD

Status: Green Apixaban

Second choice following diagnosis of AF - use in line with NICE

Status: Red Apixaban

Use following hip and knee surgery - full course of treatment supplied on discharge

Status: Red Apremilast
Status: Amber Aripiprazole tablets

Supported by ESCA. The GP should be given a rationale for prescribing rather than first line antipsychotics. Approved for use in Tourette's Syndrome.

Status: Red Arsenic trioxide

Hospital use only

Status: Red Asciminib
Status: Red Atezolizumab (Tecentriq®)
Status: Red Atezolizumab (Tecentriq®)

Hospital use only

Status: Red Avacopan (Tavneos®)

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top